Nisa Investment Advisors
MDGL icon

Nisa Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Nisa Investment Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Sell
347
-84
-19% -$43K ﹤0.01% 1276
2026
Q1 		$226K Buy
431
+2
+0.5% +$956 ﹤0.01% 1175
2025
Q4 		$250K Sell
429
-6
-1% -$3.06K ﹤0.01% 1178
2025
Q3 		$200K Buy
435
+168
+63% +$62.7K ﹤0.01% 1243
2025
Q2 		$80.8K Buy
267
+26
+11% +$7.75K ﹤0.01% 1461
2025
Q1 		$79.8K Buy
241
+1
+0.4% +$329 ﹤0.01% 1457
2024
Q4 		$74.1K Buy
240
+29
+14% +$8.16K ﹤0.01% 1557
2024
Q3 		$44.8K Buy
211
+68
+48% +$17.4K ﹤0.01% 1675
2024
Q2 		$40.1K Buy
143
+14
+11% +$3.33K ﹤0.01% 1729
2024
Q1 		$34.4K Buy
129
+13
+11% +$3.06K ﹤0.01% 1742
2023
Q4 		$26.8K Sell
116
-90
-44% -$15.7K ﹤0.01% 1785
2023
Q3 		$30.1K Buy
206
+90
+78% +$16.9K ﹤0.01% 1880
2023
Q2 		$26.8K Sell
116
-120
-51% -$32.5K ﹤0.01% 1980
2023
Q1 		$57K Buy
236
+140
+146% +$38.1K ﹤0.01% 1673
2022
Q4 		$28K Hold
96
– – ﹤0.01% 1954
2022
Q3 		$7K Sell
96
-117
-55% -$8.13K ﹤0.01% 2246
2022
Q2 		$15K Sell
213
-115
-35% -$8.45K ﹤0.01% 2111
2022
Q1 		$32K Sell
328
-1,447
-82% -$122K ﹤0.01% 1955
2021
Q4 		$102K Sell
1,775
-1,067
-38% -$87.7K ﹤0.01% 1512
2021
Q3 		$227K Sell
2,842
-3
-0.1% -$259 ﹤0.01% 1360
2021
Q2 		$277K Sell
2,845
-300
-10% -$35.5K ﹤0.01% 1307
2021
Q1 		$368K Hold
3,145
– – ﹤0.01% 1260
2020
Q4 		$350K Buy
3,145
+728
+30% +$89K ﹤0.01% 1276
2020
Q3 		$287K Sell
2,417
-1,864
-44% -$202K ﹤0.01% 1206
2020
Q2 		$485K Buy
+4,281
New +$421K ﹤0.01% 1033

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nisa Investment Advisors's MDGL Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 19% in Q2 2026, selling an estimated $43K and leaving 347 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #1276.

Nisa Investment Advisors first reported a position in MDGL in Q2 2020 and has held it in 25 quarters since. The position peaked at $485K in Q2 2020. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Nisa Investment Advisors held 347 shares of Madrigal Pharmaceuticals worth $186K as of Q2 2026.
  • Nisa Investment Advisors sold 84 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $43K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1276 holding.
  • Nisa Investment Advisors first reported a position in Madrigal Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Nisa Investment Advisors's Madrigal Pharmaceuticals position peaked at $485K in Q2 2020.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.